Cancer prevention by tea: Evidence from laboratory studies
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 64 (2), 113-122
- https://doi.org/10.1016/j.phrs.2011.03.001
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Tea catechins as inhibitors of receptor tyrosine kinases: Mechanistic insights and human relevancePharmacological Research, 2010
- Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in miceFood and Chemical Toxicology, 2010
- Inhibition of lung cancer growth in mice by dietary mixed tocopherolsMolecular Nutrition & Food Research, 2009
- Cancer prevention by tea: animal studies, molecular mechanisms and human relevanceNature Reviews Cancer, 2009
- Epigenetic modulation of the retinoid X receptor α by green tea in the azoxymethane‐ApcMin/+ mouse model of intestinal cancerMolecular Carcinogenesis, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- (-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 KinaseOnline Journal of Public Health Informatics, 2008
- (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cellsCarcinogenesis: Integrative Cancer Research, 2008
- Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformationMolecular Carcinogenesis, 2007
- Inhibition of carcinogenesis by tea constituentsSeminars in Cancer Biology, 2007